Speaker(s): 

Jonathan Spahr, MD, Director, Peds Pulmonology, Geisinger - has nothing to disclose.

Jessie Ehnot, RPH, Ambulatory Clinical Pharmacist, Geisinger - has nothing to disclose.

Angela Wislosky, RDN, Clinical Dietitian, Geisinger - has nothing to disclose.

Sara Reed, MS, Certified Genetic Counselor, Geisinger - has nothing to disclose.

Erin Redding LCSW, Social Worker, Geisinger - has nothing to disclose.

Moderator(s): 

Frank Maffei, MD, Chair of Pediatrics, Geisinger, JWCH - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Compare CF care 20 years ago to what it is today
• Highlight 2 major advances in CF that have led to better survival and outcomes
  • Newborn screening
  • Highly Effective Modulator Therapy

The Planning Committee consisting of Frank Maffei, MD, Amy Diehl, BSN, RN, CPN, Joan Keehan, RPH, Sandra Heller, and Connie Winter have no identified disclosures. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None